Hemolysis-associated pulmonary hypertension in thalassemia. - Wikidata - wikimedia - TriplyDB

Hemolysis-associated pulmonary hypertension in thalassemia.

Hemolysis-associated pulmonary hypertension in thalassemia.

http://www.wikidata.org/entity/Q34474615

about

Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell disease A narrative review of peri-operative management of patients with thalassaemia Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia Developmental changes in arginase expression and activity in the lung NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines.Pulmonary hypertension in patients with hematological disorders following splenectomy.Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension?Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease Pulmonary hypertension in well-transfused thalassemia major patients Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report Pleiotropic effects of intravascular haemolysis on vascular homeostasis.Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy.Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability Low micromolar intravascular cell-free hemoglobin concentration affects vascular NO bioavailability in sickle cell disease: a computational analysis Pulmonary hypertension in sickle cell disease: relevance to children.Premature atherosclerosis in children with beta-thalassemia major: New diagnostic marker.Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease.Effects of Aged Stored Autologous Red Blood Cells on Human Endothelial Function Post splenectomy related pulmonary hypertension.Vascular dysfunction in a murine model of severe hemolysis.Non-transfusion-dependent thalassemias.Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension Hypoxic upregulation of arginase II in human lung endothelial cells Arginase: an emerging key player in the mammalian immune system.Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy Pulmonary hypertension associated with thalassemia syndromes.Nitric oxide metabolites and arginase I levels in β-thalassemic patients: an Egyptian study.Acquired Amino Acid Deficiencies: A Focus on Arginine and Glutamine.Pulmonary hypertension in non-transfusion-dependent thalassemia: Correlation with clinical parameters, liver iron concentration, and non-transferrin-bound iron.Arginase and arginine dysregulation in asthma.Inhaled nitrite reverses hemolysis-induced pulmonary vasoconstriction in newborn lambs without blood participation.Response to "efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up " Haematologica 2014;99(2):e17-18.Frequency of pulmonary hypertension in asymptomatic β-thalassemia major patients and the role of physiological parameters in evaluation.Hypoxia biomarkers, oxidative stress, and circulating microparticles in pediatric patients with thalassemia in Upper Egypt.Vascular dysfunction in patients with young β-thalassemia: relation to cardiovascular complications and subclinical atherosclerosis.Pathways to pulmonary hypertension in sickle cell disease: the search for prevention and early intervention.

P2860

Q24606163-11AC5B07-1379-4CB3-896C-48A0E00E6062 Q27008301-F14F9FC4-8094-4F01-A717-BEC900E452E8 Q28395387-DDAFACF8-2865-4454-BEC2-0AE2F551FF5F Q28579809-AA7F4D34-34A2-469C-9045-AEBB53B869FD Q30435470-17C93021-D2E3-4CCE-B0EC-544DB677B88A Q33404045-333E78EA-43C6-4AF0-85A8-47372325D388 Q33790168-CEB80815-659D-442F-A0B3-ACE432EEF105 Q34579250-52B69C82-EB00-4410-B325-C3F1E1E9AC63 Q34734804-3A1C3775-17D8-475F-942D-2E01321299F1 Q34979478-E02507A6-CFB7-4012-8F29-C0B198618BD8 Q35243386-BC55F2D6-FA8B-4F61-92F6-4FAFEA52CA4F Q35346284-A5F3191F-0D21-449D-937E-FC8F9B8E8BB4 Q35535204-5BE3DD81-86A7-44E1-967D-12FE4960A2FF Q35590733-016D5544-9D75-430E-9B1A-155C8B4290FB Q35743427-0B411507-0F08-4348-BF53-F0FDDCC979C9 Q35750972-82BA3E81-6FD2-44C4-AD38-B37EC0EB5518 Q35902356-8F484D51-862E-4311-890F-207557AD7D03 Q36120873-46D99958-474D-4F86-96F7-4032C0062B20 Q36303189-06DCE885-7D68-4D18-9D9F-72C498E32FD4 Q36384658-4C4AC6BF-637E-456D-87E6-9154133DDE90 Q36516529-7A017A6A-D455-40B4-B3DD-881FCF3D6830 Q36653460-75C00139-A8C9-406B-A30D-F66C42668683 Q36742507-91EC5041-E28F-4BCC-8456-B33D797D3F4B Q36892558-D65E423D-A11B-42BA-97F7-A14AE2025DC3 Q37144856-A80CAFF2-DB97-43CB-BF5E-11AC543A4B98 Q37174204-CB52CA91-3294-4732-8A27-EE1BAAEE9772 Q37395887-F869AF65-BFAC-46EA-9CAB-C38E5C60408C Q37415993-91C8BAE6-2F49-4AFC-8AFE-CD1C0BBB30DE Q38786355-4223B992-A639-4B2F-8BFA-F2133E0456DC Q38987725-40DE243E-0D91-4B37-BD84-7D03C4D97160 Q39226887-FCB26153-F3BE-46C6-ACCF-2A4A21E6D6A1 Q41745150-4A7334BB-386D-4416-A191-2E770EC65490 Q41831572-4FD9C431-9375-46C9-8792-8BA0CD544BB7 Q41898158-5358F1BF-8C09-4D8A-BA8B-1B5AE08354DD Q42632177-9CB7D508-1C82-465F-85EA-B97011512B67 Q45800063-673173CE-1613-40BD-9A6A-E1AB61E9B59A Q45901373-ED692574-2677-406E-8821-804EEB2F4D2A Q46168149-DB7F304C-808D-4EEF-AE78-F47BF3CEAF38 Q47799282-74B5AB92-6AF0-4464-AA0C-B135B49DD538

P2860

Hemolysis-associated pulmonary hypertension in thalassemia.

http://www.wikidata.org/entity/Q34474615

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Hemolysis-associated pulmonary hypertension in thalassemia.

@ast

Hemolysis-associated pulmonary hypertension in thalassemia.

@en

Hemolysis-associated pulmonary hypertension in thalassemia.

@nl

type

label

Hemolysis-associated pulmonary hypertension in thalassemia.

@ast

Hemolysis-associated pulmonary hypertension in thalassemia.

@en

Hemolysis-associated pulmonary hypertension in thalassemia.

@nl

prefLabel

Hemolysis-associated pulmonary hypertension in thalassemia.

@ast

Hemolysis-associated pulmonary hypertension in thalassemia.

@en

Hemolysis-associated pulmonary hypertension in thalassemia.

@nl

P1433

Q34474615-88B09C74-D294-44C9-B259-47433B7ABFE6

P1476

Q34474615-8C1559F9-EE77-4BD5-BE83-1B4561E29C9E

P2093

Q34474615-0742CB3A-B255-46AF-AC8E-C469B765960A

Q34474615-3D4562E7-A5E1-48D6-8D57-8EB32ED7F0F3

Q34474615-68642CE9-F5C1-44F8-8C80-FE1D7F1D91BB

Q34474615-E982889A-2153-41A2-8F0C-07CAA4770DBE

Q34474615-ED15720E-6792-44DE-B80E-ACDC50BE1BFA

P2860

Q34474615-0A45F9C8-20A3-4768-9137-752E6556EE76

Q34474615-1971C253-2603-4CE7-A8D8-2511C114884E

Q34474615-1C46B579-710B-47BA-8E9A-E082501FEF52

Q34474615-283C679E-4342-4D81-8926-5C46158E1D86

Q34474615-2E5B282B-32B7-4961-8EC6-78A944C1CC02

Q34474615-672BCA44-40C2-40DE-A546-51BA3A241F83

Q34474615-689A8344-4768-42A1-80CE-52E7B3B3B807

Q34474615-6E5E5132-87EB-43DA-A541-66C51CD7FADA

Q34474615-72478D51-A6EE-40F6-A2CD-D5D696828671

Q34474615-7B0823B4-8F27-4C67-B9F4-10DA9920FE95

P304

Q34474615-15DD4B08-6CF8-42CA-A109-C05CFE68483E

P31

Q34474615-91062A0F-B6BD-417D-A808-CE95690F031D

P356

Q34474615-E9D525A8-8C85-4F36-8E8C-8B8B6AEAB786

P407

Q34474615-D9A9E2D9-064D-4EEB-B7B8-FC3102F9D0F9

P478

Q34474615-ACEF23E0-AAD0-44F2-AED7-FF21C1596CF3

P50

Q34474615-181783C2-7137-4578-8272-3D58F5E4EB35

Q34474615-45E8A339-9E7D-4491-A832-97E83F23A224

P577

Q34474615-1EDB1E03-5BE5-4057-A06C-B8DAAD834B47

P5875

Q34474615-1213E4E3-A9E8-4E77-956D-2DE39FD39C2F

P698

Q34474615-252AF5E5-3B4E-4C0C-A134-F2EC06574E76

P932

Q34474615-B76E014F-AD19-4F8F-B04E-43DA20618CB9

P356

ANNALS.1345.058

P1433

Annals of the New York Academy of Sciences

P1476

Hemolysis-associated pulmonary hypertension in thalassemia.

@en

P2093

Claudia R Morris

http://www.w3.org/2001/XMLSchema#string

Frans A Kuypers

http://www.w3.org/2001/XMLSchema#string

Lisa Lavrisha

http://www.w3.org/2001/XMLSchema#string

Sandra Larkin

http://www.w3.org/2001/XMLSchema#string

Titi Singer

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line

Arginine metabolism: nitric oxide and beyond

Regulation of enzymes of the urea cycle and arginine metabolism

Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease.

Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease

The hypercoagulable state in thalassemia.

Human type II arginase: sequence analysis and tissue-specific expression.

Expression of the liver form of arginase in erythrocytes.

Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/beta-thalassaemic patients.

P304

481-485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1196/ANNALS.1345.058

http://www.w3.org/2001/XMLSchema#string

P407

P478

1054

http://www.w3.org/2001/XMLSchema#string

P50

Elliott Vichinsky

Gregory J. Kato

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7429505

http://www.w3.org/2001/XMLSchema#string

P698

16339702

http://www.w3.org/2001/XMLSchema#string

P932

3217300

http://www.w3.org/2001/XMLSchema#string